This site is intended for healthcare professionals only
Four companies have been issued with fines totalling more than £35 million by the UK's competition watchdog for entering into illegal arrangements that resulted in a 700% increase on the NHS price of prochlorperazine.
Alliance Pharmaceuticals, Focus Pharmaceuticals and the wholesaler Lexon entered into an agreement that restricted the competition for the supply of prochlorperazine 3mg dissolvable tablets to the NHS between June 2013 and July 2018, according to a Competition and Markets Authority (CMA) statement released today (February 3).
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.
C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…
Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.
Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.
Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.
